These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1307933)

  • 1. Characteristics of (-)-stepholidine on the firing activity of substantia nigral dopamine neurons after repeated reserpine treatment.
    Sun BC; Jin GZ
    Biol Signals; 1992; 1(6):331-8. PubMed ID: 1307933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Stepholidine acts as a D1 partial agonist on firing activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine-lesioned rats.
    Sun BC; Zhang XX; Jin GZ
    Life Sci; 1996; 59(4):299-306. PubMed ID: 8761001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated reserpine treatment alters firing pattern and responses of substantia nigral dopamine neurons.
    Sun BC; Huang KX; Jin GZ
    Eur J Pharmacol; 1993 Feb; 231(3):331-8. PubMed ID: 8095463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of (-)-stepholidine and D1 or D2 agonists on unit firing of globus pallidus in 6-hydroxydopamine-lesioned rats.
    Zhang XX; Zhu ZT; Jin GZ
    Life Sci; 1998; 63(7):537-44. PubMed ID: 9718079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual actions of (-)-stepholidine on the dopamine receptor-mediated adenylate cyclase activity in rat corpus striatum.
    Dong ZJ; Guo X; Chen LJ; Han YF; Jin GZ
    Life Sci; 1997; 61(4):465-72. PubMed ID: 9244373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D1 dopamine receptor stimulation inhibits firing activity of midbrain dopamine neurons in reserpine treated rats: an effect eliminated after hemitransection of diencephalon.
    Sun BC; Chouvet G; Jin GZ
    Synapse; 1996 Sep; 24(1):29-38. PubMed ID: 9046074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action sites of rotation and unit firing induced by l-stepholidine and DA agonists in basal ganglia of 6-OHDA-lesioned rats.
    Zhang XX; Liu J; Fu Y; Hu GY; Jin GZ
    Zhongguo Yao Li Xue Bao; 1999 Nov; 20(11):979-86. PubMed ID: 11270978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-stepholidine vs 12-chloroscoulerine enantiomers on firing activity of substantia nigral dopamine neurons.
    Zhang XX; Jin GZ
    Zhongguo Yao Li Xue Bao; 1996 Jan; 17(1):18-22. PubMed ID: 8737445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological study on biphasic firing activity elicited by D(1) agonistic-D(2) antagonistic action of (-)-stepholidine in nucleus accumbens.
    Zhu ZT; Fu Y; Hu GY; Jin GZ
    Sheng Li Xue Bao; 2000 Apr; 52(2):123-30. PubMed ID: 11961581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of receptor reserve in D1 agonistic action of (-)-stepholidine in lesioned rats.
    Zou LL; Liu J; Jin GZ
    Biochem Pharmacol; 1997 Jul; 54(2):233-40. PubMed ID: 9271327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of (-)-stepholidine on firing activity of dopamine neurons in ventral tegmental area of rats.
    Sun BC; Jin GZ
    Zhongguo Yao Li Xue Bao; 1992 Sep; 13(5):395-9. PubMed ID: 1300038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons.
    Gui ZH; Liu J; Wang Y; Ali U; Wang T; Chen L
    Chin J Physiol; 2011 Apr; 54(2):96-104. PubMed ID: 21789890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-stepholidine: a dopamine receptor antagonist shows agonistic effect on rotational behavior in 6-hydroxydopamine-lesioned rats.
    Huang KX; Sun BC; Jin GZ
    Zhongguo Yao Li Xue Bao; 1992 Jan; 13(1):17-22. PubMed ID: 1605028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual actions of (-)-stepholidine on dopamine receptor subtypes after substantia nigra lesion.
    Jin GZ; Huang KX; Sun BC
    Neurochem Int; 1992 Mar; 20 Suppl():175S-178S. PubMed ID: 1365421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical neuroleptic properties ofl-stepholidine : Electrophysiological and behavioral studies.
    Zhang X; Sun B; Jin G
    Sci China C Life Sci; 1997 Oct; 40(5):531-8. PubMed ID: 20229306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum.
    Dong ZJ; Chen LJ; Jin GZ; Creese I
    Biochem Pharmacol; 1997 Jul; 54(2):227-32. PubMed ID: 9271326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.